Page last updated: 2024-10-25

eflornithine and Alopecia

eflornithine has been researched along with Alopecia in 7 studies

Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.

Alopecia: Absence of hair from areas where it is normally present.

Research Excerpts

ExcerptRelevanceReference
" Moreover, assessment of biochemical hyperandrogenism is necessary, particularly in patients with unclear or absent hirsutism, and will include assessing total and free testosterone (T), and possibly dehydroepiandrosterone sulfate (DHEAS) and androstenedione, although these latter contribute limitedly to the diagnosis."4.93Androgen excess: Investigations and management. ( Azziz, R; Gavrilova-Jordan, L; Lizneva, D; Walker, W, 2016)
"However, DFMO treatment led to marked hair loss in PKC epsilon transgenic mice."1.32Inhibition of the development of metastatic squamous cell carcinoma in protein kinase C epsilon transgenic mice by alpha-difluoromethylornithine accompanied by marked hair follicle degeneration and hair loss. ( Ness, KJ; Oberley, TD; Verma, AK; Wheeler, DL, 2003)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's3 (42.86)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
VanSickle, EA2
Michael, J1
Bachmann, AS3
Rajasekaran, S3
Prokop, JW2
Kuzniecky, R1
Hofstede, FC1
Steindl, K1
Rauch, A1
Lipson, MH1
Bupp, CP3
Leimanis-Laurens, M1
Shukla, A1
Russell, C1
Junewick, J1
Gleason, E1
Edgerly, Y1
Wittmann, BM1
Hermosura Almazan, T1
Kabigting, FD1
Schultz, CR1
Lizneva, D1
Gavrilova-Jordan, L1
Walker, W1
Azziz, R1
Mason, H1
Colao, A1
Blume-Peytavi, U1
Rice, S1
Qureshi, A1
Pellatt, L1
Orio, F1
Atkin, SL1
Wheeler, DL1
Ness, KJ1
Oberley, TD1
Verma, AK1

Reviews

3 reviews available for eflornithine and Alopecia

ArticleYear
Dermatologic care of the transgender patient.
    Dermatology online journal, 2016, Oct-15, Volume: 22, Issue:10

    Topics: Acne Vulgaris; Alopecia; Androgen Antagonists; Androgens; Cicatrix; Dermal Fillers; Dermatology; Efl

2016
Androgen excess: Investigations and management.
    Best practice & research. Clinical obstetrics & gynaecology, 2016, Volume: 37

    Topics: 5-alpha Reductase Inhibitors; Acne Vulgaris; Alopecia; Androgen Antagonists; Androstenedione; Contra

2016
Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review.
    Clinical endocrinology, 2008, Volume: 69, Issue:6

    Topics: Acne Vulgaris; Alopecia; Anovulation; Cardiovascular Diseases; Eflornithine; Female; Hirsutism; Huma

2008

Other Studies

4 other studies available for eflornithine and Alopecia

ArticleYear
Expanding the phenotype: Four new cases and hope for treatment in Bachmann-Bupp syndrome.
    American journal of medical genetics. Part A, 2021, Volume: 185, Issue:11

    Topics: Adolescent; Adult; Alopecia; Brain; Child; Child, Preschool; Developmental Disabilities; Dicarboxyli

2021
Repurposing eflornithine to treat a patient with a rare ODC1 gain-of-function variant disease.
    eLife, 2021, 07-20, Volume: 10

    Topics: Alopecia; Child, Preschool; Dicarboxylic Acid Transporters; Drug Repositioning; Eflornithine; Exome

2021
Biochemical features of primary cells from a pediatric patient with a gain-of-function
    The Biochemical journal, 2019, 07-24, Volume: 476, Issue:14

    Topics: Alopecia; Biopsy; Cells, Cultured; Child, Preschool; Dermis; Developmental Disabilities; Dicarboxyli

2019
Inhibition of the development of metastatic squamous cell carcinoma in protein kinase C epsilon transgenic mice by alpha-difluoromethylornithine accompanied by marked hair follicle degeneration and hair loss.
    Cancer research, 2003, Jun-15, Volume: 63, Issue:12

    Topics: Administration, Oral; Alopecia; Animals; Benz(a)Anthracenes; Carcinogens; Carcinoma, Squamous Cell;

2003